Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press release datedJanuary 19, 2022 -2-
© Edgar Online, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.035 USD | -0.73% | +0.49% | -70.38% |
07-08 | Immix Biopharma Doses First Patient in US AL Amyloidosis Trial With NXC-201 | MT |
07-08 | Immix Biopharma, Inc. Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201 | CI |
Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press release datedJanuary 19, 2022 -2-
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
-70.38% | 54.15M | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-12.15% | 32.76B | |
+79.34% | 29.46B | |
-12.37% | 16.31B | |
+2.74% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |